Inactivating mutations in ARID1A are recurrent in other studies: 11% of 85 DSRCT patients, 7% of 68 DSRCT patients, with other case reports where one deleterious mutation and one variant of uncertain significance have also been observed18,19,21,28. Here, ARID1A is linked to desmoplastic small round cell tumor.